Commodore Capital as of Sept. 30, 2021
Portfolio Holdings for Commodore Capital
Commodore Capital holds 29 positions in its portfolio as reported in the September 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Iveric Bio | 11.8 | $45M | 2.8M | 16.24 | |
Aclaris Therapeutics (ACRS) | 10.4 | $39M | 2.2M | 18.00 | |
Cytokinetics Com New (CYTK) | 7.5 | $29M | 797k | 35.74 | |
Dicerna Pharmaceuticals | 6.9 | $26M | 1.3M | 20.16 | |
C4 Therapeutics Com Stk (CCCC) | 5.7 | $22M | 481k | 44.68 | |
Kura Oncology (KURA) | 4.9 | $19M | 999k | 18.73 | |
Celcuity (CELC) | 4.4 | $17M | 921k | 18.00 | |
Cogent Biosciences (COGT) | 4.2 | $16M | 1.9M | 8.41 | |
Merus N V (MRUS) | 4.2 | $16M | 718k | 22.00 | |
Cymabay Therapeutics | 4.0 | $15M | 4.2M | 3.65 | |
Satsuma Pharmaceuticals Ord | 3.8 | $15M | 3.1M | 4.66 | |
Vistagen Therapeutics Com New | 3.7 | $14M | 5.1M | 2.74 | |
Celldex Therapeutics Com New (CLDX) | 3.5 | $13M | 248k | 53.99 | |
Miragen Therapeutics (VRDN) | 2.9 | $11M | 668k | 16.45 | |
Tenaya Therapeutics (TNYA) | 2.8 | $11M | 514k | 20.65 | |
Iovance Biotherapeutics (IOVA) | 2.4 | $8.9M | 363k | 24.66 | |
Xenon Pharmaceuticals (XENE) | 2.3 | $8.9M | 579k | 15.28 | |
Protagonist Therapeutics (PTGX) | 2.3 | $8.8M | 498k | 17.72 | |
Kronos Bio (KRON) | 1.7 | $6.3M | 299k | 20.96 | |
Revolution Medicines (RVMD) | 1.6 | $6.2M | 226k | 27.51 | |
Genocea Biosciences Com New (GNCAQ) | 1.6 | $5.9M | 3.1M | 1.92 | |
Kalvista Pharmaceuticals (KALV) | 1.4 | $5.5M | 313k | 17.45 | |
Dyne Therapeutics (DYN) | 1.3 | $5.0M | 305k | 16.24 | |
Mereo Biopharma Group Ads (MREO) | 1.3 | $4.8M | 2.0M | 2.42 | |
Pmv Pharmaceuticals (PMVP) | 1.0 | $3.7M | 125k | 29.80 | |
Inventiva Sa Ads (IVA) | 1.0 | $3.7M | 263k | 14.16 | |
Bcls Acquisition Corp Com Cl A | 0.7 | $2.5M | 250k | 9.96 | |
Astria Therapeutics (ATXS) | 0.6 | $2.1M | 239k | 8.84 | |
Silverback Therapeutics (SPRY) | 0.3 | $969k | 97k | 9.97 |